Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
AUTOR(ES)
El-Zawahry, Ahmed
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=546011Documentos Relacionados
- Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines
- Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts
- Radiation for prostate cancer increases risk of rectal cancer
- Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy
- Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy